These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 9548180)
41. The relation between serum markers in the second trimester and placental pathology. A study on extremely small for gestational age fetuses. Morssink LP; de Wolf BT; Kornman LH; Beekhuis JR; van der Hall TP; Mantingh A Br J Obstet Gynaecol; 1996 Aug; 103(8):779-83. PubMed ID: 8760707 [TBL] [Abstract][Full Text] [Related]
42. Beta-human chorionic gonadotrophin levels before and after the development of pre-eclampsia. Said ME; Campbell DM; Azzam ME; MacGillivray I Br J Obstet Gynaecol; 1984 Aug; 91(8):772-5. PubMed ID: 6205679 [TBL] [Abstract][Full Text] [Related]
43. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels. Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899 [TBL] [Abstract][Full Text] [Related]
44. Elevated second trimester maternal serum beta-HCG concentrations and subsequent adverse pregnancy outcome. Gravett CP; Buckmaster JG; Watson PT; Gravett MG Am J Med Genet; 1992 Nov; 44(4):485-6. PubMed ID: 1279970 [TBL] [Abstract][Full Text] [Related]
45. Multiple marker second trimester serum screening for pre-eclampsia. Wald NJ; Morris JK J Med Screen; 2001; 8(2):65-8. PubMed ID: 11480445 [TBL] [Abstract][Full Text] [Related]
46. Maternal serum endostatin at gestational weeks 16-20 is elevated in subsequent pre-eclampsia but not in intrauterine growth retardation. Wathén KA; Ylikorkala O; Andersson S; Alfthan H; Stenman UH; Vuorela P Acta Obstet Gynecol Scand; 2009; 88(5):593-8. PubMed ID: 19308751 [TBL] [Abstract][Full Text] [Related]
47. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women. Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128 [TBL] [Abstract][Full Text] [Related]
48. [Evaluating the applicability of MoM in second trimester maternal serum to screening for Down's syndrome in Jiangsu province]. Xu BY; Hu Y; Zhang CY; Zhang JW; Liu QL; Yue H; Ru T; Xu ZF; Zhu RF; Zhang Y; Zhong X; Wu QM Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):32-5. PubMed ID: 18247300 [TBL] [Abstract][Full Text] [Related]
50. Predictive Value of Second-Trimester Biomarkers and Maternal Features for Adverse Pregnancy Outcomes. Yefet E; Kuzmin O; Schwartz N; Basson F; Nachum Z Fetal Diagn Ther; 2017; 42(4):285-293. PubMed ID: 28395283 [TBL] [Abstract][Full Text] [Related]
51. Serum hyperglycosylated human chorionic gonadotrophin at 14-17 weeks of gestation does not predict preeclampsia. Keikkala E; Ranta JK; Vuorela P; Leinonen R; Laivuori H; Väisänen S; Marttala J; Romppanen J; Pulkki K; Stenman UH; Heinonen S Prenat Diagn; 2014 Jul; 34(7):699-705. PubMed ID: 24464955 [TBL] [Abstract][Full Text] [Related]
52. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin-dependent diabetes: implications for screening for Down's syndrome. Wald NJ; Cuckle HS; Densem JW; Stone RB Br J Obstet Gynaecol; 1992 Jan; 99(1):51-3. PubMed ID: 1372176 [TBL] [Abstract][Full Text] [Related]
53. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler. Spencer K; Yu CK; Cowans NJ; Otigbah C; Nicolaides KH Prenat Diagn; 2005 Oct; 25(10):949-53. PubMed ID: 16086443 [TBL] [Abstract][Full Text] [Related]
54. Decreased PAPP-A is associated with preeclampsia, premature delivery and small for gestational age infants but not with placental abruption. Ranta JK; Raatikainen K; Romppanen J; Pulkki K; Heinonen S Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):48-52. PubMed ID: 21482016 [TBL] [Abstract][Full Text] [Related]
55. The usefulness of hCG and unconjugated oestriol in prenatal diagnosis of trisomy 18. Leporrier N; Herrou M; Herlicoviez M; Leymarie P Br J Obstet Gynaecol; 1996 Apr; 103(4):335-8. PubMed ID: 8605130 [TBL] [Abstract][Full Text] [Related]
56. The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome. Spencer K; Crossley JA; Aitken DA; Nix AB; Dunstan FD; Williams K Ann Clin Biochem; 2003 May; 40(Pt 3):219-31. PubMed ID: 12803832 [TBL] [Abstract][Full Text] [Related]
57. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome. Spencer K Prenat Diagn; 2000 Aug; 20(8):652-6. PubMed ID: 10951476 [TBL] [Abstract][Full Text] [Related]
58. ADAM12s in maternal serum as a potential marker of pre-eclampsia. Spencer K; Cowans NJ; Stamatopoulou A Prenat Diagn; 2008 Mar; 28(3):212-6. PubMed ID: 18264967 [TBL] [Abstract][Full Text] [Related]
59. The association between hypertensive disorders of pregnancy and abnormal second-trimester maternal serum levels of hCG and alpha-fetoprotein. Morssink LP; Heringa MP; Beekhuis JR; De Wolf BT; Mantingh A Obstet Gynecol; 1997 May; 89(5 Pt 1):666-70. PubMed ID: 9166297 [TBL] [Abstract][Full Text] [Related]
60. Second-trimester Maternal Serum Screening Biomarkers in the Risk Assessment for Preeclampsia. Long W; Zhou Q; Wang H; Lu B; Chen Y; Zhang B; Zhou W; Yu B Ann Clin Lab Sci; 2018 May; 48(3):308-313. PubMed ID: 29970433 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]